Zobrazeno 1 - 10
of 71
pro vyhledávání: '"Laura B, Oswald"'
Autor:
Lisa M. Gudenkauf, Rina S. Fox, Brian D. Gonzalez, Heather S. L. Jim, John M. Salsman, David E. Victorson, Stacy D. Sanford, Laura B. Oswald
Publikováno v:
Cancers, Vol 16, Iss 10, p 1910 (2024)
The population of young adults (YAs) aged 18–39 living with advanced cancer is growing and faces a compounded set of challenges at the intersection of age and disease. Despite these substantial challenges, behavioral interventions tailored to YAs l
Externí odkaz:
https://doaj.org/article/01f358c82490474cb2dbf02f4ee65925
Autor:
Laura B. Oswald, Lisa M. Gudenkauf, Xiaoyin Li, Gabriel De Avila, Lauren C. Peres, Kedar Kirtane, Brian D. Gonzalez, Aasha I. Hoogland, Oanh Nguyen, Yvelise Rodriguez, Rachid C. Baz, Kenneth H. Shain, Melissa Alsina, Frederick L. Locke, Ciara Freeman, Omar Castaneda Puglianini, Taiga Nishihori, Hien Liu, Brandon Blue, Ariel Grajales-Cruz, Heather S. L. Jim, Doris K. Hansen
Publikováno v:
Cancers, Vol 15, Iss 19, p 4711 (2023)
Idecabtagene vicleucel (ide-cel) was the first FDA-approved chimeric antigen receptor T-cell therapy for relapsed/refractory multiple myeloma (RRMM) patients. This was the first study to evaluate patient-reported outcomes (PROs) among RRMM patients r
Externí odkaz:
https://doaj.org/article/a15db1658ca5412090eb9f37cd05b031
Autor:
Danielle B. Tometich, Aasha I. Hoogland, Brent J. Small, Michelle C. Janelsins, Crystal Bryant, Yvelise Rodriguez, Brian D. Gonzalez, Xiaoyin Li, Hailey W. Bulls, Brian W. James, Bianca Arboleda, Claudia Colon-Echevarria, Mary K. Townsend, Shelley S. Tworoger, Paulo Rodriguez, Laura B. Oswald, Julienne E. Bower, Sachin M. Apte, Robert M. Wenham, Hye Sook Chon, Mian M. Shahzad, Heather S. L. Jim
Publikováno v:
Cancers, Vol 15, Iss 15, p 3882 (2023)
Little is known regarding associations between inflammatory biomarkers and objectively measured physical activity and sleep during and after chemotherapy for gynecologic cancer; thus, we conducted a longitudinal study to address this gap. Women with
Externí odkaz:
https://doaj.org/article/c359b1ac05e446ea9ed011ad179d243c
Autor:
Laura B. Oswald, Brandy Arredondo, Mika Kadono, Dinorah Martinez‐Tyson, Cathy D. Meade, Frank Penedo, Michael H. Antoni, Hatem Soliman, Ricardo L. B. Costa, Heather S. L. Jim
Publikováno v:
Cancer Medicine, Vol 10, Iss 14, Pp 4823-4831 (2021)
Abstract Background Cyclin‐dependent kinase 4 and 6 (CDK4/6) inhibitor targeted therapies dramatically improve survival outcomes for metastatic breast cancer (MBC), but they are associated with significant symptom burden that can impact patients’
Externí odkaz:
https://doaj.org/article/0d7b4bc3a39f41bfb36711188b356892
Autor:
Aasha I. Hoogland, Brent J. Small, Laura B. Oswald, Crystal Bryant, Yvelise Rodriguez, Brian D. Gonzalez, Xiaoyin Li, Michelle C. Janelsins, Hailey W. Bulls, Brian W. James, Bianca Arboleda, Claudia Colon-Echevarria, Mary K. Townsend, Shelley S. Tworoger, Paulo C. Rodriguez, Julienne E. Bower, Sachin M. Apte, Robert M. Wenham, Heather S. L. Jim
Publikováno v:
Cancers, Vol 15, Iss 13, p 3407 (2023)
Previous research suggests that inflammation triggers cancer-treatment-related symptoms (i.e., fatigue, depression, and disruptions in sleep and physical activity), but evidence is mixed. This study examined relationships between inflammatory biomark
Externí odkaz:
https://doaj.org/article/9ac3eee986da4395b2cffcdfcdb79d2e
Autor:
Betina Yanez, Laura B. Oswald, Alyssa N. Van Denburg, Sharon H. Baik, Katherine A. Czech, Diana Buitrago, Carly Maletich, Katy Wortman, Frank J. Penedo, David E. Victorson
Publikováno v:
Contemporary Clinical Trials Communications, Vol 26, Iss , Pp 100898- (2022)
Background: Approximately 80% of breast cancer survivors are prescribed oral endocrine therapy (ET) medication for 5–10 years following primary treatment, making adherence to ET a critical aspect of cancer survivorship care. Despite the benefits of
Externí odkaz:
https://doaj.org/article/bf99657a354f40ac843fdfbb8c29b9dd
Autor:
Kea Turner, Margarita Bobonis Babilonia, Cristina Naso, Oliver Nguyen, Brian D Gonzalez, Laura B Oswald, Edmondo Robinson, Jennifer Elston Lafata, Robert J Ferguson, Amir Alishahi Tabriz, Krupal B Patel, Julie Hallanger-Johnson, Nasrin Aldawoodi, Young-Rock Hong, Heather S L Jim, Philippe E Spiess
Publikováno v:
Journal of Medical Internet Research, Vol 24, Iss 1, p e29635 (2022)
BackgroundRapid implementation of telehealth for cancer care during COVID-19 required innovative and adaptive solutions among oncology health care providers and professionals (HPPs). ObjectiveThe aim of this qualitative study was to explore oncology
Externí odkaz:
https://doaj.org/article/2769f2aa2e4c418c88285ff22569cdcf
Autor:
Laura B. Oswald, Rachel Kasimer, Katherine Rappazzo, Angela J. Fought, David F. Penson, Alicia K. Morgans
Publikováno v:
Cancer Medicine, Vol 9, Iss 3, Pp 980-987 (2020)
Abstract Background Metastatic prostate cancer is incurable, but systemic therapies can improve quality of life and prolong survival. Accurate perceptions of treatment risks and benefits are vital as patients with metastatic disease make treatment de
Externí odkaz:
https://doaj.org/article/a94820519a1c474cb66b1f90955e941a
Autor:
Laura B. Oswald, Xiaoyin Li, Rodrigo Carvajal, Aasha I. Hoogland, Lisa M. Gudenkauf, Doris K. Hansen, Melissa Alsina, Frederick L. Locke, Yvelise Rodriguez, Nathaly Irizarry-Arroyo, Edmondo J. Robinson, Heather S. L. Jim, Brian D. Gonzalez, Kedar Kirtane
Publikováno v:
Cancers, Vol 14, Iss 11, p 2742 (2022)
Background: Clinicians must closely monitor patients for toxicities after chimeric antigen receptor T-cell therapy (CAR-T). Patient-reported outcomes (PROs) (e.g., toxicities, quality of life) and activity data (e.g., steps, sleep) may complement cli
Externí odkaz:
https://doaj.org/article/c770d17704074793aa6a6102a11d9c62
Autor:
Xiaoyin Li, Siddhartha Roy, Jennifer Damonte, Hyun Y. Park, Aasha I. Hoogland, Kala Jamison, Khaled R. Komrokji, Chang Dong Yeo, Youngchul Kim, Jasreman Dhillon, Lisa M. Gudenkauf, Laura B. Oswald, Heather S.L. Jim, Kosj Yamoah, Julio M. Pow-Sang, Peter A. Kanetsky, Clement K. Gwede, Jong Y. Park, Brian D. Gonzalez
Publikováno v:
Cancer Epidemiology, Biomarkers & Prevention. 32:768-775
Background: Prostate cancer affects African American men disproportionately compared with men of other racial/ethnic groups. To identify biological bases for this health disparity, we sought to create a state-wide biobank of African American prostate